We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+19.81%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.09B
AUM Growth
+$372M
Cap. Flow
+$40.1M
Cap. Flow %
1.92%
Top 10 Hldgs %
62.92%
Holding
395
New
51
Increased
91
Reduced
205
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 3.61%
2 Healthcare 2.08%
3 Financials 1.85%
4 Consumer Discretionary 1.42%
5 Industrials 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
226
Vertex Pharmaceuticals
VRTX
$123B
$420K 0.02%
1,446
-49
-3% -$13.3K
TD icon
227
Toronto Dominion Bank
TD
$200B
$419K 0.02%
9,378
-1,155
-11% -$49.2K
OTIS icon
228
Otis Worldwide
OTIS
$27.8B
$415K 0.02%
+7,284
New +$377K
TGT icon
229
Target
TGT
$67.1B
$415K 0.02%
3,464
-915
-21% -$104K
FISV
230
Fiserv Inc
FISV
$28.9B
$412K 0.02%
4,218
-77
-2% -$7.75K
CI icon
231
Cigna
CI
$71.5B
$394K 0.02%
2,097
+55
+3% +$10.4K
FTV icon
232
Fortive
FTV
$18.5B
$392K 0.02%
9,180
+2,047
+29% +$79.9K
DTD icon
233
WisdomTree US Total Dividend Fund
DTD
$1.68B
$389K 0.02%
8,640
NOW icon
234
ServiceNow
NOW
$121B
$379K 0.02%
4,685
+85
+2% +$6K
EW icon
235
Edwards Lifesciences
EW
$51.2B
$374K 0.02%
5,407
+67
+1% +$4.76K
PM icon
236
Philip Morris
PM
$294B
$371K 0.02%
5,305
-203
-4% -$14.8K
EXPD icon
237
Expeditors International
EXPD
$23.7B
$362K 0.02%
4,766
+22
+0.5% +$1.61K
AZN icon
238
AstraZeneca
AZN
$250B
$360K 0.02%
3,402
+117
+4% +$12.1K
AME icon
239
Ametek
AME
$58.4B
$354K 0.02%
3,954
-12
-0.3% -$1.01K
CAT icon
240
Caterpillar
CAT
$401B
$350K 0.02%
2,775
-226
-8% -$26.8K
KMX icon
241
CarMax
KMX
$8.04B
$349K 0.02%
3,898
+16
+0.4% +$1.25K
INTU icon
242
Intuit
INTU
$89.7B
$344K 0.02%
1,159
-22
-2% -$6.04K
EQIX icon
243
Equinix
EQIX
$104B
$343K 0.02%
488
+11
+2% +$7.44K
GWW icon
244
W.W. Grainger
GWW
$60.7B
$342K 0.02%
1,089
-33
-3% -$9.54K
SCHW
245
Charles Schwab
SCHW
$188B
$341K 0.02%
10,090
-50
-0.5% -$1.79K
TM icon
246
Toyota
TM
$220B
$340K 0.02%
2,705
-866
-24% -$107K
CHRW icon
247
C.H. Robinson
CHRW
$17.9B
$338K 0.02%
4,287
-55
-1% -$4.15K
BKNG icon
248
Booking.com
BKNG
$160B
$335K 0.02%
5,250
-925
-15% -$56.3K
CP icon
249
Canadian Pacific Kansas City
CP
$80.4B
$335K 0.02%
6,575
-55
-0.8% -$2.61K
EMR icon
250
Emerson Electric
EMR
$91B
$333K 0.02%
5,370
-227
-4% -$12.9K

Similar funds

Ballentine Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Ballentine Partners held 395 positions worth $2.09B, up 22% from $1.72B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Ballentine Partners's Q2 2020 filing shows 51 new, 91 increased, 205 reduced and 22 closed positions. Its largest new stake was Invesco FTSE RAFI US 1000 ETF: 144,105 shares worth $3.12M. The largest sale was Vanguard Real Estate ETF, an estimated $18.2M.

By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.4% a quarter earlier, followed by Healthcare and Financials.

  • Ballentine Partners's largest Q2 2020 buy was Invesco FTSE RAFI US 1000 ETF: 144,105 shares worth $3.12M.
  • Ballentine Partners added most to iShares Core S&P Total US Stock Market ETF in Q2 2020, an estimated $32.1M increase.
  • Ballentine Partners's biggest Q2 2020 reduction was Vanguard Real Estate ETF, cutting an estimated $18.2M.
  • Ballentine Partners fully exited Agilent Technologies in Q2 2020, selling an estimated $866K.
  • Ballentine Partners's ten largest holdings make up 63% of its $2.09B portfolio in Q2 2020.
  • Ballentine Partners opened 51 new positions and closed 22 in Q2 2020.
  • Ballentine Partners's portfolio value rose 22% quarter-over-quarter to $2.09B.

Based on Ballentine Partners's 13F filing for Q2 2020, filed 31 Jul 2020.